vTv Therapeutics Inc. (VTVT)

NASDAQ: VTVT · Real-Time Price · USD

21.03

-0.71 (-3.27%)

Nov 6, 2026, 4:00 PM EST - Market closed

vTv Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	77.16	88.93	36.75	9.45	12.13	13.42
Short-Term Investments	-	-	-	0.07	0.02	0.1
Cash & Short-Term Investments	77.16	88.93	36.75	9.51	12.14	13.52
Cash Growth	-21.66%	142.02%	286.35%	-21.66%	-10.17%	120.91%
Accounts Receivable	-	-	-	0.1	0.17	0.06
Other Receivables	-	-	-	-	-	0.14
Receivables	-	-	-	0.1	12.42	0.19
Prepaid Expenses	1.44	0.63	1.15	1.04	2.54	1.91
Other Current Assets	-	0.34	0.22	-	-	-
Total Current Assets	78.6	89.89	38.11	10.66	27.09	15.62
Property, Plant & Equipment	-	-	-	0.36	0.56	0.68
Long-Term Investments	-	-	-	-	5.59	9.17
Other Long-Term Assets	0	0.01	0.15	-	-	-
Total Assets	78.61	89.9	38.27	11.02	33.24	25.47

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	7.02	1.13	0.94	4.08	2.46	1.88
Accrued Expenses	-	5.43	4.09	6.17	4.85	6.15
Short-Term Debt	-	-	-	0.19	0.22	0.26
Current Portion of Leases	-	-	0.17	0.17	0.15	0.18
Current Unearned Revenue	-	-	-	0.02	0.02	0.04
Other Current Liabilities	-	0.08	-	-	-	-
Total Current Liabilities	7.02	6.64	5.2	10.62	7.71	8.5
Long-Term Leases	-	-	-	0.17	0.34	0.49
Long-Term Unearned Revenue	1.83	18.67	18.67	18.67	18.67	-
Other Long-Term Liabilities	0.07	0.15	0.1	0.11	0.68	1.26
Total Liabilities	8.92	25.46	23.97	29.57	27.4	10.25

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.04	0.04	0.03	0.03	0.03	0.9
Additional Paid-In Capital	396.88	391.09	311.89	256.34	254.76	238.19
Retained Earnings	-327.23	-326.69	-299.72	-281.04	-265.52	-248.83
Total Common Equity	69.69	64.44	12.2	-24.68	-10.74	-9.74
Minority Interest	-	-	2.1	6.13	16.58	24.96
Shareholders' Equity	69.69	64.44	14.3	-18.55	5.84	15.22
Total Liabilities & Equity	78.61	89.9	38.27	11.02	33.24	25.47

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	-	0.17	0.53	0.72	0.93
Net Cash (Debt)	77.16	88.93	36.58	8.98	11.43	12.58
Net Cash Growth	-21.38%	143.14%	307.23%	-21.38%	-9.20%	141.84%
Net Cash Per Share	6.21	10.56	6.34	4.31	5.95	8.03
Filing Date Shares Outstanding	12.42	12.41	6.58	2.43	2.04	1.67
Total Common Shares Outstanding	12.42	12.41	6.58	2.08	2.04	1.67
Working Capital	71.58	83.25	32.92	0.04	19.39	7.12
Book Value Per Share	5.61	5.19	1.85	-11.84	-5.27	-5.82
Tangible Book Value	69.69	64.44	12.2	-24.68	-10.74	-9.74
Tangible Book Value Per Share	5.61	5.19	1.85	-11.84	-5.27	-5.82
Machinery	-	-	-	0.12	0.12	0.1
Leasehold Improvements	-	-	-	0.41	0.41	0.41

SEC Filings: 10-K · 10-Q